127 related articles for article (PubMed ID: 14764608)
41. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
42. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.
Kimkong I; Avihingsanon Y; Hirankarn N
Lupus; 2009 Oct; 18(12):1066-72. PubMed ID: 19762380
[TBL] [Abstract][Full Text] [Related]
43. p202 levels are negatively regulated by serum growth factors.
Geng Y; D'Souza S; Xin H; Walter S; Choubey D
Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
45. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
[TBL] [Abstract][Full Text] [Related]
46. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
[TBL] [Abstract][Full Text] [Related]
47. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
[TBL] [Abstract][Full Text] [Related]
48. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
49. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
50. Inflammasome polymorphisms in juvenile systemic lupus erythematosus.
Pontillo A; Reis EC; Liphaus BL; Silva CA; Carneiro-Sampaio M
Autoimmunity; 2015; 48(7):434-7. PubMed ID: 26182076
[TBL] [Abstract][Full Text] [Related]
51. The murine p202 protein, an IFN-inducible modulator of transcription, is activated by the mitogen platelet-derived growth factor.
Flati V; Frati L; Gulino A; Martinotti S; Toniato E
J Interferon Cytokine Res; 2001 Feb; 21(2):99-103. PubMed ID: 11244574
[TBL] [Abstract][Full Text] [Related]
52. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
53. A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE).
Linker-Israeli M; Wallace DJ; Prehn JL; Nand R; Li L; Klinenberg JR
Autoimmunity; 1996; 23(3):199-209. PubMed ID: 8879455
[TBL] [Abstract][Full Text] [Related]
54. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.
Choubey D; Gutterman JU
Biochem Biophys Res Commun; 1996 Apr; 221(2):396-401. PubMed ID: 8619867
[TBL] [Abstract][Full Text] [Related]
55. An update on genetic studies of systemic lupus erythematosus.
Tsao BP
Curr Rheumatol Rep; 2002 Aug; 4(4):359-67. PubMed ID: 12126589
[TBL] [Abstract][Full Text] [Related]
56. Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus.
Zhang Z; Shi L; Song L; Ephrem E; Petri M; Sullivan KE
Arthritis Rheumatol; 2015 Mar; 67(3):785-96. PubMed ID: 25418955
[TBL] [Abstract][Full Text] [Related]
57. Correlations of Expression Levels of a Panel of Genes (
Uzrail AH; Assaf AM; Abdalla SS
Biomed Res Int; 2019; 2019():1703842. PubMed ID: 31871930
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
[TBL] [Abstract][Full Text] [Related]
59. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-gamma.
Saito H; Morita Y; Fujimoto M; Narazaki M; Naka T; Kishimoto T
J Immunol; 2000 Jun; 164(11):5833-43. PubMed ID: 10820262
[TBL] [Abstract][Full Text] [Related]
60. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression.
Liu TF; Jones BM; Wong RW; Srivastava G
Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
